Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-06-27 @ 12:16 PM
Study NCT ID:
NCT01998659
Status:
COMPLETED
Last Update Posted:
2014-11-04
First Post:
2013-11-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Single Ascending Oral Dose Phase I Study With Px-102
Sponsor:
Phenex Pharmaceuticals AG
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy | View |
Keywords: